Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCALDEN, T. A.
Right arrow Articles by EIDELMAN, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCALDEN, T. A.
Right arrow Articles by EIDELMAN, B. H.
NEUROLOGY 1976;26:987
© 1976 American Academy of Neurology

Cerebrovascular response to infused noradrenalin and its modification by a catecholamine metabolism blocker

THOMAS A. McCALDEN, M.Sc. and BENJAMIN H. EIDELMAN, M.B., B.Ch., D.Phll.

From the Department of Physiology, Medical School, University of the Witwatersrand, Johannesburg, South Africa.

Despite many studies, the cerebrovascular action of infused noradrenalin is still unclear. The study reported here tested the hypothesis that infused noradrenalin is prevented from reaching the adrenoreceptors by being avidly taken up and metabolized in the vascular smooth muscle. Cerebral blood flow was measured by the xenon133 clearance technique in nine baboons before and during blockade of the enzyme catechol-O-methyl transferase, which is known to be important in inactivation of circulating noradrenalin. The cerebral blood flow responses to noradrenalin infused at 8, 16, and 32 µg per minute were also determined. Responses indicated vasodilatation before but vasoconstriction after blockade, with a significant difference at the 8 (p < 0.025) and 16 (p < 0.05) µg per minute doses of noradrenalin. It is suggested that the cerebral circulation is normally protected against sympathetic vasoconstriction by the avid uptake and metabolism of noradrenalin in extraneuronal and possibly neuronal sites.

Dr. McCalden's address is Department of Physiology, Medical School, University of witwatersrand, Hospital St., Johannesburg, South Africa.

This study was supported by grants from the medical Research council and the Atomic Energy Board

Received for publication October 25, 1975.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
I. K. Moppett, M. J. Wild, R. W. Sherman, J. A. Latter, K. Miller, and R. P. Mahajan
Effects of ephedrine, dobutamine and dopexamine on cerebral haemodynamics: transcranial Doppler studies in healthy volunteers
Br. J. Anaesth., January 1, 2004; 92(1): 39 - 44.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by AAN Enterprises, Inc.